Literature DB >> 17804500

Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Robert H Silverman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17804500      PMCID： PMC2169107          DOI： 10.1128/JVI.01471-07

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  120 in total

Review 1.  The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation.

Authors:  Ara G Hovanessian; Just Justesen
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

2.  Regulation of mitochondrial mRNA stability by RNase L is translation-dependent and controls IFNalpha-induced apoptosis.

Authors:  F Le Roy; M Silhol; T Salehzada; C Bisbal
Journal:  Cell Death Differ       Date:  2007-04-13       Impact factor: 15.828

3.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

Review 4.  Inflammation in prostate carcinogenesis.

Authors:  Angelo M De Marzo; Elizabeth A Platz; Siobhan Sutcliffe; Jianfeng Xu; Henrik Grönberg; Charles G Drake; Yasutomo Nakai; William B Isaacs; William G Nelson
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

5.  Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase L.

Authors:  Rebecca J Duerst; Lynda A Morrison
Journal:  Virology       Date:  2006-12-06       Impact factor: 3.616

6.  An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors.

Authors:  Beihua Dong; Sanggu Kim; Seunghee Hong; Jaydip Das Gupta; Krishnamurthy Malathi; Eric A Klein; Don Ganem; Joseph L Derisi; Samson A Chow; Robert H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-18       Impact factor: 11.205

7.  Small self-RNA generated by RNase L amplifies antiviral innate immunity.

Authors:  Krishnamurthy Malathi; Beihua Dong; Michael Gale; Robert H Silverman
Journal:  Nature       Date:  2007-07-25       Impact factor: 49.962

8.  Small-molecule activators of RNase L with broad-spectrum antiviral activity.

Authors:  Chandar S Thakur; Babal Kant Jha; Beihua Dong; Jaydip Das Gupta; Kenneth M Silverman; Hongxia Mao; Hiro Sawai; Akiko O Nakamura; Amiya K Banerjee; Andrei Gudkov; Robert H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

9.  Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L.

Authors:  Christopher L Washenberger; Jian-Qiu Han; Katherina J Kechris; Babal Kant Jha; Robert H Silverman; David J Barton
Journal:  Virus Res       Date:  2007-07-02       Impact factor: 3.303

10.  A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.

Authors:  Jian-Qiu Han; Hannah L Townsend; Babal Kant Jha; Jayashree M Paranjape; Robert H Silverman; David J Barton
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103
View more
  272 in total

1.  Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity.

Authors:  Babal Kant Jha; Irina Polyakova; Patricia Kessler; Beihua Dong; Benjamin Dickerman; Ganes C Sen; Robert H Silverman
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

Review 2.  Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion.

Authors:  Søren Jensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

3.  New PARP gene with an anti-alphavirus function.

Authors:  Svetlana Atasheva; Maryna Akhrymuk; Elena I Frolova; Ilya Frolov
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 4.  New insights into the role of RNase L in innate immunity.

Authors:  Arindam Chakrabarti; Babal Kant Jha; Robert H Silverman
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

5.  Mouse retroviruses and chronic fatigue syndrome: Does X (or P) mark the spot?

Authors:  Valerie Courgnaud; Jean-Luc Battini; Marc Sitbon; Andrew L Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

6.  Functional evolution of the OAS1 viral sensor: Insights from old world primates.

Authors:  Ian Fish; Stéphane Boissinot
Journal:  Infect Genet Evol       Date:  2016-07-05       Impact factor: 3.342

7.  Structural basis for 2'-5'-oligoadenylate binding and enzyme activity of a viral RNase L antagonist.

Authors:  Kristen M Ogden; Liya Hu; Babal K Jha; Banumathi Sankaran; Susan R Weiss; Robert H Silverman; John T Patton; B V Venkataram Prasad
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

8.  Viral manipulation of host mRNA decay.

Authors:  Liang Guo; Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Future Virol       Date:  2018-02-23       Impact factor: 1.831

9.  Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis.

Authors:  William R Lagor; David W Fields; Robert C Bauer; Alison Crawford; Michael C Abt; David Artis; E John Wherry; Daniel J Rader
Journal:  Atherosclerosis       Date:  2014-01-10       Impact factor: 5.162

10.  Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responses.

Authors:  Shin-Wu Liu; George C Katsafanas; Ruikang Liu; Linda S Wyatt; Bernard Moss
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.